Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 725.65
(1.82%)
INR 725.65
(1.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.08 Billion | 1.56 Billion | -2.42 Billion | 1.55 Billion | 2.44 Billion | 1.59 Billion |
| Net Income | -4.88 Billion | -448.1 Million | -911 Million | 2.21 Billion | 1.14 Billion | 577.76 Million |
| Depreciation & Amortization | 1.03 Billion | 1.11 Billion | 1.12 Billion | 1.08 Billion | 941.6 Million | 837.04 Million |
| Deferred income taxes | - | 192.7 Million | -31.9 Million | -347.4 Million | -186.7 Million | -202.71 Million |
| Stock-based compensation | 6 Million | 500 Thousand | -13.1 Million | 51.4 Million | 56 Million | 23.89 Million |
| Change in working capital | 1.9 Billion | 7.2 Million | -3.13 Billion | -2.05 Billion | -164.5 Million | -317.96 Million |
| Other non-cash items | 1.63 Billion | 698.1 Million | 550.4 Million | 607.4 Million | 646.7 Million | 680.61 Million |
| Investing Cash Flow | -35.1 Million | -811.4 Million | -2.42 Billion | -1.06 Billion | -3.58 Billion | -1.09 Billion |
| Investments in PPE | -410.6 Million | -1.11 Billion | -2.08 Billion | -1.74 Billion | -2.68 Billion | -525.43 Million |
| Acquisitions | 10.4 Million | -12.8 Million | 1.3 Million | -1 Million | -550.1 Million | -638.57 Million |
| Investment purchases | - | -12.8 Million | - | - | -500 Million | -4 Million |
| Sales/Maturities of investments | - | 12.8 Million | - | - | 91.8 Million | 4 Million |
| Other Investing Activities | 9.7 Million | 314.5 Million | -343.6 Million | 682.8 Million | 58.9 Million | 71.77 Million |
| Financing Cash Flow | -1.05 Billion | -1.12 Billion | 3.33 Billion | 924.9 Million | 949.1 Million | -233.84 Million |
| Debt repayment | -21.4 Million | -1.3 Billion | -937.6 Million | -2.62 Billion | -1 Billion | -716.44 Million |
| Dividends payments | - | - | -107.8 Million | -197.3 Million | -156.2 Million | - |
| Common Stock Repurchased | - | - | 908.6 Million | -353.7 Million | 1.81 Billion | - |
| Common Stock Issuance | - | - | 29 Million | 2.98 Billion | 297.6 Million | 1.48 Billion |
| Other Financing Activities | 88.2 Million | 178.6 Million | 3.44 Billion | 1.12 Billion | -27.3 Million | -997.4 Million |
| Accounts receivables | 1.78 Billion | -528 Million | -145.5 Million | -2.57 Billion | 678 Million | -553.4 Million |
| Accounts payables | 73 Million | 389 Million | -238.8 Million | 966.7 Million | -280.5 Million | -509.8 Million |
| Inventory | 130.8 Million | 173.2 Million | -2.8 Billion | -152.4 Million | -657.9 Million | -307.9 Million |
| Other working capital | -79.2 Million | -27 Million | 52.2 Million | -299 Million | 95.9 Million | 1.05 Billion |
| Cash at beginning of period | 87.3 Million | 463.8 Million | 1.97 Billion | 560.4 Million | 757.2 Million | 459.52 Million |
| Cash at end of period | 84.4 Million | 87.3 Million | 463.8 Million | 1.97 Billion | 560.4 Million | 757.21 Million |
| Capital Expenditure | -410.6 Million | -1.11 Billion | -2.08 Billion | -1.74 Billion | -2.68 Billion | -525.43 Million |
| Effect of forex changes on cash | - | - | - | - | - | 25.13 Million |
| Net cash flow / Change in cash | -2.9 Million | -376.5 Million | -1.51 Billion | 1.41 Billion | -196.8 Million | 297.69 Million |
| Free Cash Flow | 678.1 Million | 449.4 Million | -4.5 Billion | -190.2 Million | -246.5 Million | 1.07 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -134.6 Million | -2.55 Billion | -4.88 Billion | -2.74 Billion | -171.6 Million | -195.5 Million |
| Depreciation & Amortization | - | - | 1.03 Billion | 259.6 Million | 262.1 Million | 259.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 6 Million | 3 Million | - | - |
| Change in working capital | - | - | 1.9 Billion | - | - | - |
| Other non-cash items | 134.6 Million | 2.55 Billion | 1.63 Billion | 2.74 Billion | 171.6 Million | 195.5 Million |
| Investing Cash Flow | - | - | -35.1 Million | - | - | - |
| Investments in PPE | - | - | -410.6 Million | - | - | - |
| Acquisitions | - | - | 10.4 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 9.7 Million | - | - | - |
| Financing Cash Flow | - | - | -1.05 Billion | - | - | - |
| Debt repayment | - | - | -21.4 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 88.2 Million | - | - | - |
| Accounts receivables | - | - | 1.78 Billion | - | - | - |
| Accounts payables | - | - | 73 Million | - | - | - |
| Inventory | - | - | 130.8 Million | - | - | - |
| Other working capital | - | - | -79.2 Million | - | - | - |
| Cash at beginning of period | - | - | 87.3 Million | 64.59 Million | -459.6 Million | 88.9 Million |
| Cash at end of period | - | - | 84.4 Million | 583.79 Million | 64.59 Million | 607.1 Million |
| Capital Expenditure | - | - | -410.6 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -2.9 Million | 519.2 Million | 524.2 Million | 518.2 Million |
| Free Cash Flow | - | - | 678.1 Million | 519.2 Million | 524.2 Million | 518.2 Million |
CPYYY
PAGS
PRKS
7707
0941
3495